Valeant Cedes Drugs To Win OK For $770M Skin Care Buys
Valeant Pharmaceuticals International Inc. said Monday that it will give up rights to three of its skin care drugs in exchange for federal approval of its plans to buy two skin...To view the full article, register now.
Already a subscriber? Click here to view full article